| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 71.18B | 69.92B | 68.19B | 65.76B | 61.34B | 58.09B |
| Gross Profit | 5.46B | 5.36B | 4.85B | 4.68B | 4.69B | 4.41B |
| EBITDA | 4.22B | 4.23B | 4.83B | 3.19B | 4.39B | 3.91B |
| Net Income | 1.52B | 1.63B | 1.19B | 737.00M | 1.48B | 971.00M |
Balance Sheet | ||||||
| Total Assets | 39.51B | 38.89B | 47.04B | 46.13B | 49.35B | 53.15B |
| Cash, Cash Equivalents and Short-Term Investments | 4.57B | 4.63B | 4.67B | 4.45B | 4.65B | 5.42B |
| Total Debt | 14.97B | 14.67B | 14.84B | 15.08B | 15.36B | 17.79B |
| Total Liabilities | 28.71B | 27.23B | 35.37B | 33.90B | 33.71B | 39.78B |
| Stockholders Equity | 10.81B | 11.67B | 11.67B | 12.24B | 15.66B | 13.39B |
Cash Flow | ||||||
| Free Cash Flow | 1.79B | 1.68B | 2.45B | 2.56B | 2.61B | -1.10B |
| Operating Cash Flow | 3.15B | 2.92B | 3.84B | 3.81B | 3.79B | 108.00M |
| Investing Cash Flow | -1.52B | -441.00M | -1.70B | -790.00M | -1.77B | 2.34B |
| Financing Cash Flow | -3.07B | -2.94B | -1.86B | -3.19B | -2.23B | -1.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £30.07B | 7.58 | 13.57% | 3.25% | 1.05% | -20.25% | |
70 Outperform | £7.54B | 11.60 | 5.08% | 4.02% | 0.82% | 160.81% | |
69 Neutral | £13.20B | 15.47 | 9.22% | 2.98% | -3.06% | -26.93% | |
68 Neutral | £1.55B | 14.01 | 20.47% | 3.34% | 8.06% | 5.15% | |
66 Neutral | £1.69B | 12.40 | 34.27% | 17.38% | 1.74% | -23.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | £1.50B | 3.62 | 24.47% | ― | ― | ― |